posted on 2024-11-15, 20:08authored byYuebiao Zhou, Star L. Garrigues, Elisia Villemure, Noriko Ishisoko, Huy Q. Nguyen, Nikkia K. Hamidi, Rebecca Vogt, Yong Wang, Robert A. Blake, Joachim Rudolph, Christian Nilewski
Stabilization of cereblon (CRBN)/neosubstrate complexes
with molecular
glues followed by degradation of those neosubstrates is an emerging
strategy in drug discovery with compelling potential to target certain
proteins that were previously considered to be undruggable. In this
context, the discovery of novel CRBN ligands is an important area
of ongoing research that holds promise to expand the scope of proteins
that can be targeted through this mode of action. Herein, we describe
the synthesis and evaluation of CRBN ligands featuring heteroaryl
glutarimide and dihydrouracil scaffolds. We identified a subset of
heteroaryl glutarimides exhibiting potent CRBN binding and increased
chemical stability in cell culture media compared with traditional
immunomodulatory drugs (IMiDs). This indicates that the scaffolds
described herein could become useful starting points for the discovery
of novel molecular glue degraders.